|
|
|
|
LEADER |
00000cam a2200000 4500 |
001 |
EBOOKCENTRAL_ocn877767343 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
140419s2013 enk ob 001 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d J2I
|d YDXCP
|d OCLCO
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d NLE
|d OCLCO
|d AU@
|d OCLCO
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d MM9
|d OCLCA
|d SFB
|d OCLCO
|d OCLCQ
|d CASUM
|d OCLCO
|
019 |
|
|
|a 857798217
|a 1289380358
|
020 |
|
|
|a 9781780842165
|
020 |
|
|
|a 1780842163
|
020 |
|
|
|a 9781780842172
|q (ePub)
|
020 |
|
|
|a 1780842171
|q (ePub)
|
020 |
|
|
|z 9781780842189
|q (print)
|
024 |
7 |
|
|a 10.2217/9781780842165
|2 doi
|
029 |
1 |
|
|a AU@
|b 000070363929
|
035 |
|
|
|a (OCoLC)877767343
|z (OCoLC)857798217
|z (OCoLC)1289380358
|
050 |
|
4 |
|a RC280.L8 P476 2013
|
060 |
|
4 |
|a WF 658
|b P476 2013eb
|
082 |
0 |
4 |
|a 616.99/424
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Komaki, Ritsuko.
|
245 |
1 |
0 |
|a Personalized Management of Lung Cancer.
|
260 |
|
|
|a London :
|b Future Medicine Ltd,
|c 2013.
|
300 |
|
|
|a 1 online resource (245 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Title page; Copyright page; Contents; Foreword. Personalized management of lung cancer; 1. Molecular subtypes of non-small-cell lung cancer; 2. Screening and risk factors; 3. Staging and prognosis; 4. Surgical approach: patient selection and clinical outcomes; 5. Radiotherapy: patient selection and clinical outcomes; 6. Adjuvant therapy for non-small-cell lung carcinoma following surgical resection; 7. Chemotherapy and molecularly targeted agents for advanced non-small-cell lung cancer; 8. Use of thoracic radiation therapy for small-cell lung cancer.
|
505 |
8 |
|
|a 9. Limited-stage small-cell lung cancer: prophylactic cranial irradiation10. Small-cell lung cancer: treatment of extensive-stage disease; 11. EGFR inhibitors: patient selections and clinical outcome; 12. Antiangiogenic therapy for non-small-cell lung cancer: patient selection and clinical outcomes; 13. Considerations of practice guidelines and recommendations; 14. Novel agents in development and future directions; Index.
|
520 |
|
|
|a Personalized Management of Lung Cancer.
|
504 |
|
|
|a Includes bibliographical references and index.
|
546 |
|
|
|a English.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Lungs
|x Cancer
|x Treatment.
|
650 |
1 |
2 |
|a Lung Neoplasms
|x therapy
|
650 |
|
6 |
|a Poumons
|x Cancer
|x Traitement.
|
650 |
|
7 |
|a Lungs
|x Cancer
|x Treatment
|2 fast
|
655 |
|
4 |
|a Internet Resources.
|
700 |
1 |
|
|a Liao, Zhongxing.
|
776 |
0 |
8 |
|i Print version:
|a Komaki, Ritsuko.
|t Personalized Management of Lung Cancer.
|d London : Future Medicine Ltd, ©2013
|z 9781780842189
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1179665
|z Texto completo
|
936 |
|
|
|a BATCHLOAD
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL1179665
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 11775476
|
994 |
|
|
|a 92
|b IZTAP
|